Listed
Stock Code: 293780
| Company Name | 압타바이오(주) |
| English Name | Aptabio Therapeutics Inc. |
| Business Reg. No. | 1358603821 |
| CEO | 이수진 |
| Address | 경기도 용인시 기흥구 흥덕1로 13 타워동 에이504호(영덕동, 흥덕아이티밸리) |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 70113 |
| Established | 2009-07-24 |
| Phone | 031-365-3693 |
| Website | www.aptabio.com |
| Regular Employees | 45persons |
| Corp. Reg. No. | 1358110168906 |
Venture Certified
| 기술평가보증기업(기금) | 2010-03-24 ~ 2012-03-23 | 20100102535 | 2010-03-24 |
| 기술평가보증기업(기금) | 2012-03-24 ~ 2014-03-23 | 20120102439 | 2010-03-24 |
| 연구개발유형 | 2014-03-24 ~ 2016-03-23 | 20140102617 | 2010-03-24 |
| 연구개발유형 | 2016-03-24 ~ 2018-03-23 | 20160102729 | 2010-03-24 |
| 연구개발유형 | 2018-03-24 ~ 2020-03-23 | 20180101559 | 2010-03-24 |
| 연구개발유형 | 2020-03-24 ~ 2022-03-23 | 20200102129 | 2010-03-24 |
| 연구개발유형 | 2022-03-24 ~ 2025-03-23 | 20220413020038 | 2010-03-24 |
| 연구개발유형 | 2025-03-24 ~ 2028-03-23 | 20250429020026 | 2010-03-24 |
Revenue CAGR +733.7%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 34B | 3.2B | 0.5B |
| Operating Profit | -188B | -164B | -95B |
| Net Profit | -280B | -147B | -106B |
| Total Assets | 772B | 925B | 561B |
| Total Liabilities | 233B | 312B | 37B |
| Total Equity | 539B | 614B | 524B |
Operating Loss: Op. profit -188B
3 Consecutive Years of Net Loss
▲ 1705.9%
▼ 45.6%
▲ 95.5%
▲ 48.8%
▼ 135.3%
| Name | Position | Role |
|---|---|---|
| 이수진 | 대표이사 | 대표 |
| NPS Subscribers | 45persons |
| CEO | 이수진 |
| Est. Avg. Annual Salary | 5,67010K (47310K/mo) |
| Hired (12 mo) | +0persons |
| Left (12 mo) | -1persons |
| Net Change (12 mo) | -1persons |
| NPS Join Date | 2009-09-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
3 Additional Data Sources
{
"address": "경기도 용인시 기흥구 흥덕1로",
"brno": "135860****",
"cappedWarning": false,
"companyName": "압타바이오주식회사",
"estimatedAvgAnnualSalary": 56700684,
"estimatedAvgMonthlySalary": 4725057,
"fetchedAt": "2026-03-05T21:33:17.169Z",
"industryCode": "730000",
"industryName": "기타 인문 및 사회과학 연구개발업",
"joinDate": "20090901",
"last12MonthsHired": 0,
"last12MonthsLeft": 1,
"last12MonthsNetChange": -1,
"leaveDate": null,
"monthlyPensionAmount": 20199620,
"monthlyTrend": [
{
"lostSubscribers": 1,
"newSubscribers": 0,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6399223",
"status": "1",
"styleCode": "1",
"subscriberCount": 45,
"turnoverMonths": 1
}{
"address": "경기도 용인시",
"ceo_name": "이수진",
"certificate": [
{
"cert_number": "20100102535",
"changes": "",
"disclosure_date": "2010-03-24",
"first_cert_date": "2010-03-24",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2010-03-24 ~ 2012-03-23"
},
{
"cert_number": "20120102439",
"changes": "",
"disclosure_date": "2012-03-23",
"first_cert_date": "2010-03-24",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-03-24 ~ 2014-03-23"
},
{
"cert_number": "20140102617",
"changes": "",
"disclosure_date": "2014-03-14",
"first_cert_date": "2010-03-24",
"no": "3",
"type": "연구개발유형",
"valid_period": "2014-03-24 ~ 2016-03-23"
},
{
"cert_number": "20160102729",
"changes": "",
"disclosure_date": "2016-03-18",
"first_cert_date": "2010-03-24",
"no": "4",
"type": "연구개발유형",
"valid_period": "2016-03-24 ~ 2018-03-23"
},
{
"cert_number": "20180101559",
"changes": "",
"disclosure_date": "2018-02-20",
"first_cert_date": "2010-03-24",
"no": "5",
"type": "연구개발유형",
"valid_period": "2018-03-24 ~ 2020-03-23"
},
{
"cert_number": "20200102129",
"changes": "",
"disclosure_date": "2020-02-28",
"first_cert_date": "2010-03-24",
"no": "6",
"type": "연구개발유형",
"valid_period": "2020-03-24 ~ 2022-03-23"
},
{
"cert_number": "20220413020038",
"changes": "",
"disclosure_date": "2022-04-13",
"first_cert_date": "2010-03-24",
"no": "7",
"type": "연구개발유형",
"valid_period": "2022-03-24 ~ 2025-03-23"
},
{
"cert_number": "20250429020026",
"changes": "",
"disclosure_date": "2025-04-29",
"first_cert_date": "2010-03-24",
"no": "8",
"type": "연구개발유형",
"valid_period": "2025-03-24 ~ 2028-03-23"
}
],
"company_name": "압타바이오 주식회사",
"financials": {
"2022": {
"capital_stock": 11149433000,
"cost_of_sales": 0,
"current_assets": 20419015000,
"current_liabilities": 1040017000,
"gross_profit": 48353000,
"net_income": -10564737000,
"net_income_bs": -10564737000,
"non_current_assets": 35694717000,
"non_current_liabilities": 2704214000,
"non_operating_expenses": 2773861000,
"non_operating_income": 1715890000,
"operating_profit": -9506766000,
"revenue": 48353000,
"sga_expenses": 9555119000,
"total_assets": 56113732000,
"total_equity": 52369501000,
"total_liabilities": 3744231000
},
"2023": {
"capital_stock": 11668219000,
"cost_of_sales": 245370000,
"current_assets": 54996067000,
"current_liabilities": 815695000,
"gross_profit": 78499000,
"net_income": -14702830000,
"net_income_bs": -12071144000,
"non_current_assets": 37531289000,
"non_current_liabilities": 30357772000,
"non_operating_expenses": 4150924000,
"non_operating_income": 5806432000,
"operating_profit": -16358338000,
"revenue": 323869000,
"sga_expenses": 16436837000,
"total_assets": 92527356000,
"total_equity": 61353889000,
"total_liabilities": 31173467000
},
"2024": {
"capital_stock": 13440680000,
"cost_of_sales": 3074364000,
"current_assets": 32930374000,
"current_liabilities": 19559136000,
"gross_profit": 286616000,
"net_income": -28019004000,
"net_income_bs": -29594114000,
"non_current_assets": 44274394000,
"non_current_liabilities": 3696638000,
"non_operating_expenses": 14465030000,
"non_operating_income": 5276869000,
"operating_profit": -18830843000,
"revenue": 3360980000,
"sga_expenses": 19117459000,
"total_assets": 77204768000,
"total_equity": 53948994000,
"total_liabilities": 23255774000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [],
"phone": "031-365-****",
"source": "pg_migration"
}{
"address": "경기도 용인시 기흥구 흥덕1로 13 (영덕동, 흥덕아이티밸리) 타워동 504호",
"employee_count": 27,
"establishment_date": "20110201",
"source": "pg_migration",
"workplace_name": "압타바이오(주)"
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| Venture System Detail | 2026-03-05 | Collected |
| comwel_insurance | 2026-03-05 | Collected |
| DART Financial | 2026-02-26 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |